GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Interojo Co 119610.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

12,890

-1.68%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Interojo Co

Its shares trade on KOSDAQ under the ticker 119610.KQ. It has been listed since 28 July 2010. In the fiscal year to 31 December 2025, it reported revenue of ₩118.44bn and net income of ₩12.94bn. At that date it held total assets of ₩244.89bn and shareholders' equity of ₩157.04bn.

INTEROJO, Inc. engages in the manufacture and sale of contact lenses. The company is headquartered in Pyeongtaek, Gyeonggi-Do. The company went IPO on 2010-07-28. The Company’s products include silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, rigid gas permeable (RGP) contact lenses and solutions. The firm distributes its products in domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
28 Jul 2010

Leadership

Pay as last reported

  • Si Cheol NohChief Executive Officer, Director
  • Chae Min YimInternal Auditor
  • Seong Chun LeeDirector
  • Wung Yeong LeeDirector
  • Dae Seop KimNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Interojo Co Ltd manufactures silicone hydrogel lenses for domestic and overseas markets.
  • The company offers sodium hyaluronate lenses and therapy lenses for specialized eye care.
  • Interojo distributes multifocal vision lenses and rigid gas permeable lenses globally.

Weaknesses

  • Interojo Co Ltd has no presence in the Financials sector for diversified revenue streams.
  • The company lacks products in the Information Technology industry for digital health solutions.
  • Interojo does not operate in the Consumer Discretionary segment for broader market reach.

Opportunities

  • Interojo can expand into the Real Estate sector for new market opportunities.
  • The company can leverage the Health Care industry for global health care partnerships.
  • Interojo may enter the Materials sector to develop innovative lens materials.

Threats

  • Interojo faces competition from other Health Care companies in the KR market.
  • The company must address potential regulatory changes in the Health Care industry.
  • Interojo needs to manage supply chain risks for contact lens manufacturing.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.